SomaLogic partners with Dante Genomics to enhance clinical and research adoption of proteomics in Europe

SomaLogic’s 7,000-plex SomaScan® Platform will be used in proteomics testing at scale in Europe. BOULDER, Colo. and L’AQUILA, Italy, July 24, 2023 /PRNewswire/ — SomaLogic Operating Co. Inc., (Nasdaq:SLGC), a leader in data-driven proteomics technology, today announced its partnership…

Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.